The Impact of Mood and Anxiety Disorders on Incident Hypertension at One Year

被引:35
|
作者
Bacon, Simon L. [1 ,2 ,3 ,4 ]
Campbell, Tavis S. [1 ,5 ]
Arsenault, Andre [1 ,4 ]
Lavoie, Kim L. [1 ,3 ,4 ,6 ]
机构
[1] Hop Sacre Coeur Montreal, Montreal Behav Med Ctr, Res Ctr, 5400 Blvd Gouin Ouest, Montreal, PQ H4J IC5, Canada
[2] Concordia Univ, Dept Exercise Sci, Montreal, PQ H4B 1R6, Canada
[3] Hop Sacre Coeur Montreal, Ctr Readaptat Jean Jacques Gauthier, Montreal, PQ H4J 1C5, Canada
[4] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada
[5] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada
[6] Univ Quebec Montreal UQAM, Dept Psychol, Montreal, PQ H3C 3P8, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1155/2014/953094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Studies assessing the association between psychological factors and hypertension have been equivocal, which may reflect limitations in the assessment of psychological factors. Purpose. To assess the relationship between mood and anxiety disorders, measured using a psychiatric interview, and 1-year incident hypertension. Methods. 197 nonhypertensive individuals undergoing exercise stress testing at baseline provided follow-up data at 1 year. Baseline assessments included a structure psychiatric interview (PRIME-MD), physician diagnosis of hypertension, and measured blood pressure. At follow-up, hypertension status was assessed via self-reported physician diagnosis. Results. Having an anxiety disorder was associated with a 4-fold increase in the risk of developing hypertension (adjusted OR = 4.14, 95% CIs = 1.18-14.56). In contrast, having a mood disorder was not associated with incident hypertension (adjusted OR = 1.21, 95% CIs = 0.24-5.86). Conclusions. There are potential mechanisms which could explain our differential mood and anxiety findings. The impact of screening and treatment of anxiety disorders on hypertension needs to be explored.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Anxiety, Mood, and Substance Use Disorders in Parents of Children With Anxiety Disorders
    Alicia A. Hughes
    Jami M. Furr
    Erica D. Sood
    Andrea J. Barmish
    Philip C. Kendall
    Child Psychiatry and Human Development, 2009, 40 : 405 - 419
  • [32] Impact of Mood Disorders
    Wagner, Karen Dineen
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (03) : 376 - 377
  • [33] Signs of Mood and Anxiety Disorders in Chimpanzees
    Ferdowsian, Hope R.
    Durham, Debra L.
    Kimwele, Charles
    Kranendonk, Godelieve
    Otali, Emily
    Akugizibwe, Timothy
    Mulcahy, J. B.
    Ajarova, Lilly
    Johnson, Cassie Mere
    PLOS ONE, 2011, 6 (06):
  • [34] Mood disorders and anxiety in hypertensive patients
    Coutinho, Danielle Sousa
    Pessoa, Tamires Marinho
    Nardi, Antonio Egidio
    de Oliveira e Silva, Adriana Cardoso
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2011, 33 : S9 - S9
  • [35] Are Mood and Anxiety Disorders Inflammatory Diseases?
    Boorman, Emily
    Romano, Graziella F.
    Russell, Alice
    Mondelli, Valeria
    Pariante, Carmine M.
    PSYCHIATRIC ANNALS, 2015, 45 (05) : 240 - 248
  • [36] Foreword: Postpartum Mood and Anxiety Disorders
    Fierman, Arthur H.
    CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE, 2017, 47 (10) : 239 - 240
  • [37] Polypharmacy for perinatal mood and anxiety disorders
    Viguera, Adele C.
    LANCET PSYCHIATRY, 2024, 11 (08): : 575 - 577
  • [38] Newer Treatments for Mood and Anxiety Disorders
    Markman, Jesse
    Combs, Heidi
    MEDICAL CLINICS OF NORTH AMERICA, 2024, 108 (05) : 911 - 921
  • [39] A GLUTAMATERGIC HYPOTHESIS OF MOOD/ANXIETY DISORDERS
    Popoli, M.
    BEHAVIOURAL PHARMACOLOGY, 2011, 22 : E12 - E13
  • [40] Agomelatine in the treatment of mood and anxiety disorders
    Baldwin, David S.
    Lopes, Antonio T.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (03) : 153 - 156